锦州奥鸿药业有限责任公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
80
NMPA:80
Drug Approvals
Fovinaciclib Citrate Capsules
- Product Name
- 复妥宁
- Approval Number
- 国药准字H20250023
- Approval Date
- May 27, 2025
NMPA
Fovinaciclib Citrate Capsules
- Product Name
- 复妥宁
- Approval Number
- 国药准字H20250024
- Approval Date
- May 27, 2025
NMPA
Diclofenac Sodium Sustained-release Tablets
- Product Name
- 双氯芬酸钠缓释片
- Approval Number
- 国药准字H20254096
- Approval Date
- May 13, 2025
NMPA
Diclofenac Sodium Sustained-release Tablets
- Product Name
- 双氯芬酸钠缓释片
- Approval Number
- 国药准字H20254097
- Approval Date
- May 13, 2025
NMPA
Metaraminol Bitartrate Injection
- Product Name
- 重酒石酸间羟胺注射液
- Approval Number
- 国药准字H20253150
- Approval Date
- Jan 14, 2025
NMPA
Citicoline Sodium Injection
- Product Name
- 胞磷胆碱钠注射液
- Approval Number
- 国药准字H20247293
- Approval Date
- Nov 27, 2024
NMPA
Dobutamine Hydrochloride Injection
- Product Name
- 盐酸多巴酚丁胺注射液
- Approval Number
- 国药准字H20247163
- Approval Date
- Jul 12, 2024
NMPA
Aripiprazole Oral Solution
- Product Name
- 阿立哌唑口服溶液
- Approval Number
- 国药准字H20243321
- Approval Date
- Mar 12, 2024
NMPA
Aripiprazole Oral Solution
- Product Name
- 阿立哌唑口服溶液
- Approval Number
- 国药准字H20243319
- Approval Date
- Mar 5, 2024
NMPA
Nifedipine Controlled-release Tablets
- Product Name
- 硝苯地平控释片
- Approval Number
- 国药准字H20234668
- Approval Date
- Dec 19, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
Clinical Trials
No trials found
News
No news found